A liberal blood transfusion strategy is safe in patients with myocardial infarction, anemia, and heart failure: lessons from MINT

2 September 2024 (10:18 - 10:30)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Andrew Michael Goldsweig

Baystate Medical Center, Springfield (United States of America)

4 More presentations in this session

Presentation thumbnail

Effect of alirocumab on coronary plaque stratified by atherothrombotic risks

Doctor Y. Ueki (Matsumoto, JP)

Abstract Slides Video

Presentation thumbnail

Lesion-level changes induced by low-density lipoprotein cholesterol lowering therapy in patients with acute myocardial infarction: the pre-specified PACMAN-AMI lesion-level analysis.

Doctor F. Biccire (Bern, CH)

Abstract Slides Video

Presentation thumbnail

Real-world evidence supports superior efficacy of prasugrel over ticagrelor in individuals with acute coronary syndrome

Doctor N. Kruger (Boston, US)

Abstract Slides Video

Presentation thumbnail

Post-PCI anticoagulation with unfractionated heparin in acute coronary syndrome: insight from the STOPDAPT-3 trial

Doctor H. Watanabe (Hirakata, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Tailored approaches to cardiovascular therapy in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

2 September 2024 10:18 CET

You may be interested in

Congress Presentation

Effects of restrictive vs liberal transfusion strategies on mortality in patients with acute myocardial infarction and anemia: The 6-month follow up primary results of the MINT trial

Congress Presentation

Cardiac diagnostics in Circulation

Congress Presentation

Effect of four hemoglobin transfusion threshold strategies in patients with acute myocardial infarction and anemia: a target trial emulation using MINT trial data

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources